Acetylcholine Receptor Myasthenia Gravis
Aug. 8, 2024
Myasthenia Gravis: Practice Essentials, Background, Anatomy Myasthenia Gravis - Stepwards CSI Pharmacy - Myasthenia Gravis is an autoimmune disorder that results from antibodies that block or destroy nicotinic acetylcholine receptors at the neuromuscular junction (NMJ). In image B below you see a Autoimmune Attack of the Neuromuscular Junction in Myasthenia Gravis: Nicotinic Acetylcholine Receptors and Other Targets | ACS Chemical Neuroscience | Acetylcholine Receptor Myasthenia Gravis
![Myasthenia Gravis – A Review of Current Therapeutic Options | [current-page:pager]t…](https://www.touchneurology.com/wp-content/uploads/sites/3/2018/12/Figure1-Pathogenic-mechanism.png){kind=link}
![PDF] Acetylcholine receptor antibody in Thai generalized myasthenia gravis patients…](https://d3i71xaburhd42.cloudfront.net/b203c456868acdba6046379d83bc2e6b9b5b0195/2-Table1-1.png){kind=link}
![PDF] Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis | Semant…](https://d3i71xaburhd42.cloudfront.net/e7df13699e934232053b030708a27aad7832f605/4-Figure2-1.png){kind=link}
